2025Q4
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Schwartz Phillip | President | 607,410 | Jan 24, 2022 |
| Toledano Miranda Jayne | CEO | 500,000 | Aug 2, 2024 |
| Yaacov-Garbeli Dana | CFO | 130,000 | Aug 2, 2024 |
| Galitzer Hillel | — | 130,000 | Apr 23, 2024 |
| Ellis Sean | Director | 120,161 | Aug 29, 2024 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 27, 2024 | Aug 29, 2024 | OSTROV GERALD M | Director | Neutral | 90.0 | +20,446 | 204.46% | ✗ | - |
| Aug 27, 2024 | Aug 29, 2024 | Taitel Haya | Director | Neutral | 90.0 | +15,335 | 43.67% | ✗ | - |
| Aug 27, 2024 | Aug 29, 2024 | Ellis Sean | Director | Neutral | 90.0 | +18,061 | 17.69% | ✗ | - |
| Aug 27, 2024 | Aug 29, 2024 | Malca Yonatan | Director | Neutral | 90.0 | +23,172 | 320.41% | ✗ | - |
| Aug 27, 2024 | Aug 29, 2024 | LIEBERMAN GERALD M | Director | Neutral | 90.0 | +27,261 | 10.83% | ✗ | - |
| Apr 19, 2024 | Aug 2, 2024 | Yaacov-Garbeli Dana | CFO | Neutral | 90.0 | +30,151 | 53.29% | ✗ | - |
| Jul 31, 2024 | Aug 2, 2024 | Toledano Miranda Jayne | CEO | Neutral | 90.0 | +124,121 | 112.07% | ✗ | - |
| Jun 7, 2024 | Burshtein Gregory | Chief of R&D | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Apr 19, 2024 | Apr 23, 2024 | Yaacov-Garbeli Dana | CFO | Neutral | 90.0 | +30,151 | 53.29% | ✗ | - |
| Apr 19, 2024 | Apr 23, 2024 | Galitzer Hillel | COO | Neutral | 90.0 | +30,151 | 88.40% | ✗ | - |
| Jan 12, 2024 | Jan 16, 2024 | Taitel Haya | Director | Buy | 90.0 | +9,500 | 37.09% | ✗ | $9.4K |
| Jan 10, 2024 | Jan 11, 2024 | Taitel Haya | Director | Buy | 90.0 | +7,615 | 42.31% | ✗ | $5.9K |
| Jan 1, 2024 | Jan 3, 2024 | Taitel Haya | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 1, 2024 | Jan 3, 2024 | GARCEAU ROGER | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 1, 2024 | Jan 3, 2024 | Malca Yonatan | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 1, 2024 | Jan 3, 2024 | OSTROV GERALD M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 1, 2024 | Jan 3, 2024 | Mayron Ron | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 1, 2024 | Jan 3, 2024 | LIEBERMAN GERALD M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 1, 2024 | Jan 3, 2024 | Ellis Sean | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 22, 2023 | Dec 27, 2023 | LIEBERMAN GERALD M | Director | Buy | 91.3 | +23,952 | 10.51% | ✗ | $17K |
| Dec 22, 2023 | Dec 27, 2023 | Toledano Miranda Jayne | CEO | Buy | 91.3 | +23,952 | 27.59% | ✗ | $17K |
| Sep 13, 2023 | Sep 14, 2023 | Taitel Haya | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 13, 2023 | Sep 14, 2023 | Toledano Miranda Jayne | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 22, 2023 | Aug 24, 2023 | Taitel Haya | Director | Buy | 91.3 | +18,000 | 100.00% | ✗ | $11.2K |
| Aug 24, 2023 | Taitel Haya | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Aug 21, 2023 | Aug 23, 2023 | LIEBERMAN GERALD M | Director | Buy | 86.3 | +20,000 | 9.13% | ✗ | $11.8K |
| Aug 21, 2023 | Aug 22, 2023 | Ellis Sean | Director | Buy | 91.3 | +40,000 | 64.41% | ✗ | $24K |
| Apr 24, 2023 | Apr 25, 2023 | Santora Arthur C II | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 24, 2023 | Apr 25, 2023 | Yaacov-Garbeli Dana | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 24, 2023 | Apr 25, 2023 | Galitzer Hillel | COO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 4, 2023 | Apr 6, 2023 | Toledano Miranda Jayne | CEO | Buy | 91.3 | +30,000 | 52.82% | ✗ | $30.3K |
| Jan 2, 2023 | Jan 4, 2023 | GARCEAU ROGER | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 2, 2023 | Jan 4, 2023 | LIEBERMAN GERALD M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 2, 2023 | Jan 4, 2023 | Mayron Ron | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 2, 2023 | Jan 4, 2023 | OSTROV GERALD M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 2, 2023 | Jan 4, 2023 | Malca Yonatan | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 2, 2023 | Jan 4, 2023 | Ellis Sean | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 11, 2022 | Nov 15, 2022 | Yaacov-Garbeli Dana | CFO | Buy | 91.3 | +56,580 | 100.00% | ✗ | $29.8K |
| Nov 14, 2022 | Nov 15, 2022 | LIEBERMAN GERALD M | Director | Buy | 91.3 | +50,000 | 29.58% | ✗ | $28.5K |
| Nov 11, 2022 | Nov 14, 2022 | Ellis Sean | Director | Buy | 91.3 | +30,000 | 93.46% | ✗ | $15.9K |
| Nov 11, 2022 | Nov 14, 2022 | Toledano Miranda Jayne | CEO | Buy | 91.3 | +50,000 | 735.29% | ✗ | $26.6K |
| Sep 7, 2022 | Sep 9, 2022 | Santora Arthur C II | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 7, 2022 | Sep 9, 2022 | Toledano Miranda Jayne | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 7, 2022 | Sep 9, 2022 | Yaacov-Garbeli Dana | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 25, 2022 | Ellis Sean | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jul 25, 2022 | Ellis Sean | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jul 21, 2022 | Jul 25, 2022 | Ellis Sean | Director | Buy | 91.3 | +14,900 | 86.63% | ✗ | $24.4K |
| Jul 21, 2022 | Jul 25, 2022 | LIEBERMAN GERALD M | Director | Buy | 91.3 | +19,491 | 13.85% | ✗ | $32.8K |
| Mar 31, 2022 | Apr 4, 2022 | Galitzer Hillel | COO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 8, 2022 | Yaacov-Garbeli Dana | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 13, 2022 | Jan 25, 2022 | OSTROV GERALD M | Director | Buy | 91.3 | +10,000 | 100.00% | ✗ | $27.4K |
| Jan 19, 2022 | Jan 24, 2022 | Ratan Ramesh | CFO | Buy | 91.3 | +10,000 | 100.00% | ✗ | $24.4K |
| Jan 18, 2022 | Jan 24, 2022 | JAMAS SPIROS | CEO | Buy | 91.3 | +10,000 | 100.00% | ✗ | $28.5K |
| Jan 20, 2022 | Jan 24, 2022 | Schwartz Phillip | President | Buy | 78.8 | +10,000 | 1.67% | ✗ | $25.3K |
| Jan 18, 2022 | Jan 24, 2022 | LIEBERMAN GERALD M | Director | Buy | 77.5 | +2,800 | 2.03% | ✗ | $7.8K |
| Jan 24, 2022 | JAMAS SPIROS | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 24, 2022 | LIEBERMAN GERALD M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 20, 2022 | JAMAS SPIROS | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 18, 2022 | Jan 19, 2022 | Mayron Ron | Director | Buy | 91.3 | +7,000 | 100.00% | ✗ | $19.6K |
| Jan 14, 2022 | Jan 19, 2022 | Toledano Miranda Jayne | Director | Buy | 91.3 | +6,800 | 100.00% | ✗ | $19K |
| Jan 18, 2022 | Jan 19, 2022 | Ellis Sean | Director | Buy | 91.3 | +10,000 | 100.00% | ✗ | $28.1K |
| Jan 13, 2022 | Jan 18, 2022 | Malca Yonatan | Director | Buy | 91.3 | +7,232 | 100.00% | ✗ | $19.8K |
| Jan 1, 2022 | Jan 14, 2022 | Ellis Sean | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 14, 2022 | Ellis Sean | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 1, 2022 | Jan 14, 2022 | Malca Yonatan | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 14, 2022 | Malca Yonatan | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 14, 2022 | Ratan Ramesh | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 14, 2022 | Santora Arthur C II | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 14, 2022 | Galitzer Hillel | COO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 1, 2022 | Jan 13, 2022 | OSTROV GERALD M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 13, 2022 | OSTROV GERALD M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 1, 2022 | Jan 11, 2022 | Toledano Miranda Jayne | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 1, 2022 | Jan 11, 2022 | LIEBERMAN GERALD M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 1, 2022 | Jan 11, 2022 | Mayron Ron | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 1, 2022 | Jan 11, 2022 | GARCEAU ROGER | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 11, 2022 | Toledano Miranda Jayne | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 11, 2022 | LIEBERMAN GERALD M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 11, 2022 | Schwartz Phillip | President | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 11, 2022 | Mayron Ron | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 11, 2022 | GARCEAU ROGER | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |